Biotech Specialty Pharma

Spherix Incorporated

6430 Rockledge Drive #503
Bethesda, MD 20817 USA
Phone
Fax
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Innovative biopharmaceutical products and consulting services.

Management Claire L. Kruger, CEO, COO; Robert A. Lodder, President; Robert L. Clayton, CFO, Treasurer; Katherine M. Brailer, Corporate Secretary and Director of Administrative Services

Click here for Financial Data
Keywords: SPEX, Type 2 diabetes, triglycerides, clinical, biotechnology, pharmaceutical companies

Comment


Updated: Dec. 08, 2014


Description

Spherix develops innovative biopharmaceutical products and provides technical and regulatory consulting services through subsidiaries Biospherics and Spherix Consulting. Biospherics has completed a gl......view more

Products / Services

D-tagatose is a novel, small molecule that has shown human proof of concept as a glycemic control and anti-hypertriglyceridemia agent in a Phase 2 and an initial Phase 3 clinical trial in Type II Diab......view more

Technology / Differentiation

SPX-106, is one of five small, non-carbohydrate molecules in-licensed by Spherix last year. D-tagatose is a novel, small molecule that has shown human proof of concept as a glycemic control agent in...view more

Market / Customers

Tagatose has the potential to compete in the multi-billion dollar dyslipidemic and diabetic markets.......view more


Strategy

Spherix is seeking development and commercialization agreements and acquisitions to support continued development of tagatose in two different indications with two different dose/dose forms: (1) Type...view more

Status

Spherix Incorporated was launched in 1967 as a scientific research company under the name Biospherics Research. The Company now leverages its scientific and technical expertise and experience through...view more

RELATED COMPANIES